Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Arzneimittel-Forschung|July 1, 1975
A new isoniazid preparation designed for moderately fast and "fast" metabolizers of the drugL Eidus, M M HodgkinAntimicrobial Agents and Chemotherapy|January 1, 1973
Screening of isoniazid inactivatorsL Eidus, M M HodgkinBulletin of the World Health Organization|January 1, 1974
Screening of isoniazid inactivators by dilution testM M Hodgkin, L Eidus, E J HamiltonCanadian Journal of Physiology and Pharmacology|July 1, 1979
Isoniazid phenotyping of black as well as white patientsM M Hodgkin, L Eidus, W C BaileyResearch Communications in Chemical Pathology and Pharmacology|May 1, 1979
Evaluation of various isoniazid slow releasing matrix preparations for intermittent chemotherapy of tuberculosisM M Hodgkin, L Eidus, E S HershfieldJournal of Clinical Microbiology|December 1, 1983
Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complexA Laszlo, P Gill, V Handzel, et al.Bulletin of the World Health Organization|January 1, 1973
Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosisL Eidus, P Varughese, M M Hodgkin, et al.Research Communications in Chemical Pathology and Pharmacology|February 1, 1979
Phenotyping of South African black tuberculosis patients for inactivation of isoniazidL Eidus, E Glatthaar, M M Hodgkin, et al.International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1979
Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacksL Eidus, E Glatthaar, M M Hodgkin, et al.Journal of Clinical Gastroenterology|September 1, 1981
Risk factors for isoniazid (NIH)-induced liver dysfunctionD S Dickinson, W C Bailey, B I Hirschowitz, et al.Pageof 2